'Is it safe?' Safety is a process, not a question

Br J Dermatol. 2012 Nov;167(5):968-9. doi: 10.1111/bjd.12074.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents / therapeutic use*
  • Female
  • Humans
  • Isoniazid / therapeutic use*
  • Latent Tuberculosis / prevention & control*
  • Male
  • Psoriasis / drug therapy*
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents
  • Ustekinumab
  • Isoniazid